SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-041995
Filing Date
2023-08-14
Accepted
2023-08-11 20:00:12
Documents
92
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q srne-20230630.htm   iXBRL 10-Q 4430618
2 EX-31.1 srne-ex31_1.htm EX-31.1 17072
3 EX-31.2 srne-ex31_2.htm EX-31.2 15714
4 EX-32.1 srne-ex32_1.htm EX-32.1 26192
  Complete submission text file 0000950170-23-041995.txt   17432187

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT srne-20230630_cal.xml EX-101.CAL 117047
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT srne-20230630.xsd EX-101.SCH 86722
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT srne-20230630_pre.xml EX-101.PRE 567080
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT srne-20230630_def.xml EX-101.DEF 397606
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT srne-20230630_lab.xml EX-101.LAB 669016
86 EXTRACTED XBRL INSTANCE DOCUMENT srne-20230630_htm.xml XML 3892331
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36150 | Film No.: 231165805
SIC: 2836 Biological Products, (No Diagnostic Substances)